Peripheral artery disease (PAD) is a common cardiovascular disease associated with increased risk of amputation, myocardial infarction, stroke, and death, as well as impaired quality of life (QOL), ...

Of initially stable patients with non–ST‐segment–elevation myocardial infarction, 43% are treated in an intensive care unit (ICU), but only 14% ultimately develop complications requiring ICU care ...

Introduction The global vascular access device market is undergoing substantial expansion, propelled by the rising incidence of chronic conditi ...

Its use extends to dialysis solutions, wound care products, and even as a nasal rinse, highlighting its versatility and indispensability in modern healthcare. What Factors Are Driving Growth in the ...

Inc. (Peripheral Vascular) POD Detachable with dedicated anchor segment for high flow vessel sacrifice High-flow microcatheter deliverable Indicated for arterial and venous embolizations in the ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

The ongoing rollout of Vafseo is currently focused on dialysis patients, but there is also potential in the non-dialysis segment, with a Phase 3 trial anticipated in the second half of 2025. The ...

CorMedix recently initiated a Phase 3 study for the reduction of Central Line Associated Blood ... $31.2 million of revenues in Q4. Outpatient dialysis continues to account for the vast majority ...